New program aims to help young men stay out of prison after release

NCT ID NCT04785677

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a program called RISE (Resiliency in Stressful Experiences) for young men ages 18-35 leaving state prisons in Florida. The program combines trauma counseling with practical help like housing and job support. Researchers measured whether participants had better housing stability, employment, and mental health, and whether they were less likely to return to prison.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Resiliency in Stressful Experiences (RISE) Program
What this could lead to
If successful, this program could help young men leaving prison find stable housing and jobs, reduce psychological distress, and lower the chance of returning to prison.
What could go wrong
This is a completed behavioral study, so results are already known. The program may not work for everyone, and its effects depend on individual participation and local support services.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGGRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute stress disorder Aggression anxiety anxiety disorder Depression Impulsive Behavior injury occupation-related stress disorder Occupational Stress post-traumatic stress disorder Recidivism Stress Disorders, Traumatic Stress Disorders, Traumatic, Acute substance abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute for Justice Research and Development

    Tallahassee, Florida, 32310, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.